Left vs Left Randomized Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2136 participants.

Also called NCT05650658

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,136 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05650658
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05650658. Randomized; triple masking; primary purpose treatment. Start 2023-09-13 (actual); primary completion 2029-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Left vs Left Randomized Clinical Trial
Condition
Heart Failure
Condition
AV Block
Condition
LBBB
Condition
RBBB
Condition
Intraventricular Conduction Delay
Condition
Pacing-Induced Cardiomyopathy
Intervention (Device)
His/LBBP
Intervention (Device)
BiVP
Lead sponsor
Baylor College of Medicine (class: other)
Collaborator
Patient-Centered Outcomes Research Institute (class: other)
Collaborator
University of Utah (class: other)
Collaborator
Virginia Commonwealth University (class: other)
Collaborator
Cleveland Clinic Florida (class: other)
Collaborator
East Carolina University (class: other)

Record details

Record id
cardio:ct-nct05650658
Content hash
ae6a7454acf57a2d39482b98a452d26189550d5bb08be17c1f7adea982bf5933